Moss Genomics Inc. (MOSS.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13 | 55 | 43 | 1 | 15 |
| Receivables | 29 | 25 | 24 | 21 | 21 |
| Other current assets | 3,504 | 1,076 | 418 | 0 | 0 |
| TOTAL | $3,562 | $1,175 | $485 | $28 | $41 |
| Non-Current Assets | |||||
| PPE Net | 16 | 21 | 26 | 31 | 36 |
| TOTAL | $16 | $21 | $26 | $31 | $36 |
| Total Assets | $3,578 | $1,196 | $511 | $59 | $77 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 5 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 133 | 124 | 183 | 87 | N/A |
| Accrued Expenses | 0 | 30 | 0 | 1 | N/A |
| TOTAL | $233 | $259 | $183 | $88 | $87 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 5 | 35 | 30 |
| Deferred Revenues | 100 | 100 | N/A | N/A | N/A |
| TOTAL | $0 | $0 | $5 | $35 | $30 |
| Total Liabilities | $233 | $259 | $188 | $123 | $117 |
| Shareholders' Equity | |||||
| Common Shares | 2,972 | 2,972 | 2,517 | 1,483 | 1,483 |
| Retained earnings | -877 | -2,286 | -2,367 | -1,682 | -1,624 |
| Other shareholders' equity | 1,250 | 251 | 172 | 135 | 100 |
| TOTAL | $3,346 | $937 | $322 | $-64 | $-40 |
| Total Liabilities And Equity | $3,578 | $1,196 | $511 | $59 | $77 |